Technology & Software Global On demand · 24-48h

Global Artificial Intelligence in Medicine Market Strategic Research Report

Global Artificial Intelligence in Medicine Market Strategic …

$3,500 USD

Strategic Research Report

Global Artificial Intelligence in Medicine Market

$37.73B2025

36.1%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Hardware, Software, Services

By Application: Auxiliary Diagnosis, Drug Discovery, Health Management, Hospital Management, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: NVIDIA, Intel, IBM, Google Health, Microsoft, AWS, GE Healthcare, Siemens Healthineers, Medtronic, Atomwise, Zebra Medical Vision, Cyrcadia Health, AiCure, Alibaba, BPGbio, Medasense Biometrics, Hindsait, Dell, SAP

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 123 pages

Market size 2025

$37.73B

Billion USD

Forecast CAGR

36.1%

2025-2032

Forecast 2032

$326.4B

Projected

Regions

Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Artificial Intelligence in Medicine market size is predicted to grow from US$ 37,730 million in 2025 to US$ 319,290 million in 2032; it is expected to grow at a CAGR of 36.1% from 2026 to 2032.

Artificial intelligence (AI) is technology patterned after the brain’s neural network sand uses multiple layers of information – including algorithms, pattern matching, rules, deep learning and cognitive computing – to learn how to understand data. Medicine artificial intelligence (AI) mainly uses computer techniques to perform clinical diagnoses and suggest treatments. AI has the capability of detecting meaningful relationships in a data set and has been widely used in many clinical situations to diagnose, treat, and predict the results.

The development of artificial intelligence in medicine is advancing rapidly and will continue to have a profound impact on medical practice and patient care.

Although AI has shown great potential in the medical field, it also faces some challenges, including data privacy issues, ethical considerations, regulatory barriers, and the reliability and transparency of AI systems. In the future, with the advancement of technology and the improvement of regulations, AI will play a more important role in the medical field and promote the development of the medical industry in a more efficient and accurate direction.

Global key players of artificial intelligence in medicine include NVIDIA, Intel, IBM, Google Health, Siemens Healthineers, etc. The top five players hold a share over 26%. North America is the largest market, has a share about 42%, followed by Europe, and Asia-Pacific, with share 32% and 21%, separately.

This report presents a comprehensive overview of the global Artificial Intelligence in Medicine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Hardware
Software
Services

Segment by players, this report covers

NVIDIA
Intel
IBM
Google Health
Microsoft
AWS
GE Healthcare
Siemens Healthineers
Medtronic
Atomwise
Zebra Medical Vision
Cyrcadia Health
AiCure
Alibaba
BPGbio
Medasense Biometrics
Hindsait
Dell
SAP

Segment by Application

Auxiliary Diagnosis
Drug Discovery
Health Management
Hospital Management
Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Artificial Intelligence in Medicine market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Auxiliary Diagnosis, Drug Discovery, Health Management evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Artificial Intelligence in Medicine Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 36.1%

Regional growth momentum

Market share by segment

Key metrics

Base value

$37.73B

2025

Forecast

$326.4B

2032

CAGR

36.1%

2025–2032

Regions

global

Key companies

NVIDIAIntelIBMGoogle HealthMicrosoftAWSGE HealthcareSiemens Healthineers

Segments covered in this report

By Type

HardwareSoftwareServices

By Application

Auxiliary DiagnosisDrug DiscoveryHealth ManagementHospital ManagementOthers

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Hardware
3.1.3 Software
3.1.4 Services
3.1.5 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Auxiliary Diagnosis
4.1.3 Drug Discovery
4.1.4 Health Management
4.1.5 Hospital Management
4.1.6 Others
4.1.7 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 NVIDIA
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Intel
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 IBM
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 Google Health
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 Microsoft
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 AWS
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 GE Healthcare
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 Siemens Healthineers
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 Medtronic
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 Atomwise
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Zebra Medical Vision
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 Cyrcadia Health
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 AiCure
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 Alibaba
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)
8.15 BPGbio
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2026–2032)
8.16 Medasense Biometrics
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2026–2032)
8.17 Hindsait
8.17.1 Company Overview
8.17.2 Key Products & Segments
8.17.3 Financial Performance (2023–2025)
8.17.4 Business Strategy
8.17.5 SWOT Analysis
8.17.6 Strategic Implications (2026–2032)
8.18 Dell
8.18.1 Company Overview
8.18.2 Key Products & Segments
8.18.3 Financial Performance (2023–2025)
8.18.4 Business Strategy
8.18.5 SWOT Analysis
8.18.6 Strategic Implications (2026–2032)
8.19 SAP
8.19.1 Company Overview
8.19.2 Key Products & Segments
8.19.3 Financial Performance (2023–2025)
8.19.4 Business Strategy
8.19.5 SWOT Analysis
8.19.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Artificial Intelligence in Medicine market?

The global Artificial Intelligence in Medicine market is estimated at US$ 37.73 billion in 2025 (base year) and is projected to reach US$ 319.29 billion by 2032.

How fast is the Artificial Intelligence in Medicine market expected to grow?

The market is expected to grow at a CAGR of 36.1% from 2026 to 2032, expanding from US$ 37.73 billion in 2025 to US$ 319.29 billion in 2032, roughly 8.5 times its base-year value.

What does the Artificial Intelligence in Medicine market cover?

How is the Artificial Intelligence in Medicine market segmented by type?

By type, the market is segmented into Hardware, Software and Services.

What are the key applications of Artificial Intelligence in Medicine?

Key applications covered include Auxiliary Diagnosis, Drug Discovery, Health Management, Hospital Management and Others.

Which companies are profiled in the Artificial Intelligence in Medicine market report?

Key players profiled include NVIDIA, Intel, IBM, Google Health, Microsoft, AWS, GE Healthcare and Siemens Healthineers, among 19 companies covered in total.

What geographies does the Artificial Intelligence in Medicine market analysis include?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What are the main risks and barriers in the Artificial Intelligence in Medicine market?

Who should buy the Artificial Intelligence in Medicine market report?

The report is intended for manufacturers and solution providers, distributors and end users in Auxiliary Diagnosis, Drug Discovery and Health Management, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Artificial Intelligence in Medicine market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.